Exact Mass: 373.16376280000003

Exact Mass Matches: 373.16376280000003

Found 57 metabolites which its exact mass value is equals to given mass value 373.16376280000003, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

Clebopride

4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-methoxybenzamide

C20H24ClN3O2 (373.1556954)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

Sepimostat

6-Amidino-2-naphthyl-(4-(4,5-dihydro-1H-imidazol-2-yl)amino)benzoate dimethanesulfonate

C21H19N5O2 (373.1538674)


   
   
   
   
   

(2Z)-5-{[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]amino}-2-pentenyl 3-methylbutanoate

(2Z)-5-{[(2E,4E,6E)-7-(2-thienyl)-2,4,6-heptatrienoyl]amino}-2-pentenyl 3-methylbutanoate

C21H27NO3S (373.17115520000004)


   

(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-yliden)-amin|(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-yliden)-amine|1,5,5-trimethyl-2,2-diphenyl-1,2,2,4-tetrahydro-4,4-azanylylidene-bis-pyrazol-3-one|Methylrubazonsaeure

(1,5-Dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-yliden)-amin|(1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazol-4-yl)-(3-methyl-5-oxo-1-phenyl-1,5-dihydro-pyrazol-4-yliden)-amine|1,5,5-trimethyl-2,2-diphenyl-1,2,2,4-tetrahydro-4,4-azanylylidene-bis-pyrazol-3-one|Methylrubazonsaeure

C21H19N5O2 (373.1538674)


   

Gly Asn Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C14H23N5O7 (373.1597408)


   

Gly Asn Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O7 (373.1597408)


   

Gly Pro Asn Ser

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C14H23N5O7 (373.1597408)


   

Gly Pro Ser Asn

(2S)-2-[(2S)-2-{[(2S)-1-(2-aminoacetyl)pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C14H23N5O7 (373.1597408)


   

Gly Ser Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O7 (373.1597408)


   

Gly Ser Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-(2-aminoacetamido)-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C14H23N5O7 (373.1597408)


   

Asn Gly Pro Ser

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C14H23N5O7 (373.1597408)


   

Asn Gly Ser Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-carbamoylpropanamido]acetamido}-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O7 (373.1597408)


   

Asn Pro Gly Ser

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-hydroxypropanoic acid

C14H23N5O7 (373.1597408)


   

Asn Pro Ser Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]acetic acid

C14H23N5O7 (373.1597408)


   

Asn Ser Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]acetyl}pyrrolidine-2-carboxylic acid

C14H23N5O7 (373.1597408)


   

Asn Ser Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O7 (373.1597408)


   

Pro Gly Asn Ser

(2S)-2-[(2S)-3-carbamoyl-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]-3-hydroxypropanoic acid

C14H23N5O7 (373.1597408)


   

Pro Gly Ser Asn

(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-{2-[(2S)-pyrrolidin-2-ylformamido]acetamido}propanamido]propanoic acid

C14H23N5O7 (373.1597408)


   

Pro Asn Gly Ser

(2S)-2-{2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}-3-hydroxypropanoic acid

C14H23N5O7 (373.1597408)


   

Pro Asn Ser Gly

2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]acetic acid

C14H23N5O7 (373.1597408)


   

Pro Ser Gly Asn

(2S)-3-carbamoyl-2-{2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]acetamido}propanoic acid

C14H23N5O7 (373.1597408)


   

Pro Ser Asn Gly

2-[(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]acetic acid

C14H23N5O7 (373.1597408)


   

Ser Gly Asn Pro

(2S)-1-[(2S)-2-{2-[(2S)-2-amino-3-hydroxypropanamido]acetamido}-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C14H23N5O7 (373.1597408)


   

Ser Gly Pro Asn

(2S)-2-{[(2S)-1-{2-[(2S)-2-amino-3-hydroxypropanamido]acetyl}pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C14H23N5O7 (373.1597408)


   

Ser Asn Gly Pro

(2S)-1-{2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]acetyl}pyrrolidine-2-carboxylic acid

C14H23N5O7 (373.1597408)


   

Ser Asn Pro Gly

2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}acetic acid

C14H23N5O7 (373.1597408)


   

Ser Pro Gly Asn

(2S)-2-(2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}acetamido)-3-carbamoylpropanoic acid

C14H23N5O7 (373.1597408)


   

Ser Pro Asn Gly

2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]acetic acid

C14H23N5O7 (373.1597408)


   

Clebopride

Clebopride

C20H24ClN3O2 (373.1556954)


A - Alimentary tract and metabolism > A03 - Drugs for functional gastrointestinal disorders > A03F - Propulsives > A03FA - Propulsives D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist D005765 - Gastrointestinal Agents > D000932 - Antiemetics D002491 - Central Nervous System Agents

   

1,1-DIPHENYL-3-(PIPERIDIN-1-YL)PROPYL METHANESULFONATE

1,1-DIPHENYL-3-(PIPERIDIN-1-YL)PROPYL METHANESULFONATE

C21H27NO3S (373.17115520000004)


   

3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1H-indol-2-one

3,3-bis(4-hydroxy-3,5-dimethylphenyl)-1H-indol-2-one

C24H23NO3 (373.16778480000005)


   

Sepimostat

Sepimostat

C21H19N5O2 (373.1538674)


D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors C471 - Enzyme Inhibitor > C783 - Protease Inhibitor Sepimostat (FUT-187 free base) exhibits neuroprotective activity via NR2B N-methyl-D-aspartate receptor antagonism at the Ifenprodil-binding site of the NR2B subunit. Sepimostat inhibits the Ifenprodil binding with a Ki value of 27.7?μM[1].

   

N N-BIS((R)-(+)-1-PHENYLETHYL)PHTHALAMI&

N N-BIS((R)-(+)-1-PHENYLETHYL)PHTHALAMI&

C24H23NO3 (373.16778480000005)


   

N-(5-CHLORO-3-((4-(DIETHYLAMINO)-2-METHYLPHENYL)IMINO)-4-METHYL-6-OXOCYCLOHEXA-1,4-DIEN-1-YL)ACETAMIDE

N-(5-CHLORO-3-((4-(DIETHYLAMINO)-2-METHYLPHENYL)IMINO)-4-METHYL-6-OXOCYCLOHEXA-1,4-DIEN-1-YL)ACETAMIDE

C20H24ClN3O2 (373.1556954)


   

N-(3,4,6-TRI-O-ACETYL-β-D-GLUCOPYRANOSYL) PIPERIDINE

N-(3,4,6-TRI-O-ACETYL-β-D-GLUCOPYRANOSYL) PIPERIDINE

C17H27NO8 (373.1736582)


   

1-[(E)-(Dimethylamino)methylene]-3-tritylthiourea

1-[(E)-(Dimethylamino)methylene]-3-tritylthiourea

C23H23N3S (373.16125980000004)


   
   

S1RA hydrochloride

S1RA hydrochloride

C20H24ClN3O2 (373.1556954)


S1RA (E-52862) hydrochloride is an orally active and selective sigma-1 receptor (σ1R) antagonist with a Ki value of 17 nM. S1RA hydrochloride shows good selectivity against σ2R (Ki >1000 nM). S1RA hydrochloride is a human 5-HT2B receptor antagonist with an IC50 value of 4.7 μM. S1RA hydrochloride inhibits neuropathic pain and activity-induced spinal sensitization[1][2].

   
   

N,N-BIS((S)-1-PHENYLETHYL) PHTHALAMIC ACID

N,N-BIS((S)-1-PHENYLETHYL) PHTHALAMIC ACID

C24H23NO3 (373.16778480000005)


   

(4s)-(-)-4,5-dihydro-2-[2-(diphenylphosphino)phenyl]-4-isopropyloxazole

(4s)-(-)-4,5-dihydro-2-[2-(diphenylphosphino)phenyl]-4-isopropyloxazole

C24H24NOP (373.1595424)


   

(R)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-isopropyl-2-oxazoline

(R)-(+)-2-[2-(Diphenylphosphino)phenyl]-4-isopropyl-2-oxazoline

C24H24NOP (373.1595424)


   
   

1-[Tert-butyl-[(3,5-dimethylphenyl)-oxomethyl]amino]-3-(4-chlorophenyl)urea

1-[Tert-butyl-[(3,5-dimethylphenyl)-oxomethyl]amino]-3-(4-chlorophenyl)urea

C20H24ClN3O2 (373.1556954)


   

5-[1-[(3,5-Dimethoxyphenyl)methylamino]propylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

5-[1-[(3,5-Dimethoxyphenyl)methylamino]propylidene]-1-prop-2-enyl-1,3-diazinane-2,4,6-trione

C19H23N3O5 (373.16376280000003)


   

N-[2-(4-methoxyphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline

N-[2-(4-methoxyphenoxy)ethyl]-5-(4-morpholinyl)-2-nitroaniline

C19H23N3O5 (373.16376280000003)


   

2-Phenylbutanoic acid [2-oxo-2-(2-phenylanilino)ethyl] ester

2-Phenylbutanoic acid [2-oxo-2-(2-phenylanilino)ethyl] ester

C24H23NO3 (373.16778480000005)


   

1-(4-chlorophenyl)-N-(2-furanylmethyl)-N-[[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]methanamine

1-(4-chlorophenyl)-N-(2-furanylmethyl)-N-[[1-(2-methylbutan-2-yl)-5-tetrazolyl]methyl]methanamine

C19H24ClN5O (373.1669284)


   

(4E,8E)-10-(4,6-dihydroxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate

(4E,8E)-10-(4,6-dihydroxy-7-methyl-3-oxo-1,3-dihydro-2-benzofuran-5-yl)-4,8-dimethyldeca-4,8-dienoate

C21H25O6- (373.165105)


   

2-[[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]-1,3-thiazole

2-[[(1R,5S)-7-[4-[(E)-2-phenylethenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methyl]-1,3-thiazole

C23H23N3S (373.16125980000004)


   

(4-fluorophenyl)-[(1R,5S)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone

(4-fluorophenyl)-[(1R,5S)-7-[4-(3-pyridinyl)phenyl]-3,6-diazabicyclo[3.1.1]heptan-3-yl]methanone

C23H20FN3O (373.1590322)


   

2-[(1,5-Dimethyl-3-oxo-2-phenylpyrazol-4-yl)diazenyl]-3-(2-methylphenyl)-3-oxopropanenitrile

2-[(1,5-Dimethyl-3-oxo-2-phenylpyrazol-4-yl)diazenyl]-3-(2-methylphenyl)-3-oxopropanenitrile

C21H19N5O2 (373.1538674)